Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Queensland Health
Argus Health
QuintilesIMS
Cantor Fitzgerald
McKesson
Covington
Harvard Business School
US Department of Justice
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

ULTRALENTE INSULIN Drug Profile

« Back to Dashboard

When do Ultralente Insulin patents expire, and what generic alternatives are available?

Ultralente Insulin is a drug marketed by Novo Nordisk Inc and is included in one NDA.

The generic ingredient in ULTRALENTE INSULIN is insulin zinc susp extended beef. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin zinc susp extended beef profile page.
Summary for ULTRALENTE INSULIN
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 4,093
Drug Prices:see details
DailyMed Link:ULTRALENTE INSULIN at DailyMed
Drug patent expirations by year for ULTRALENTE INSULIN

US Patents and Regulatory Information for ULTRALENTE INSULIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc ULTRALENTE INSULIN insulin zinc susp extended beef INJECTABLE;INJECTION 017997-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Novartis
US Department of Justice
Cantor Fitzgerald
Argus Health
Chubb
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot